Orcosa Inc.

BiotechnologyBiotechnologyB2BCannabinoid Therapeutics

📍 Ewing, NJ, United States• Founded 2020• 11-50 employees

StreetZero Signal 76

Be the first to signal interest

About Orcosa Inc.

ORCOSA Inc is a privately held biotechnology company founded in 2020 and headquartered in Ewing, New Jersey. It develops cannabinoid-based therapeutics, including an investigational CBD tablet for acute pain, with a focus on oncology and neurological disorders. The company operates in the B2B space with 11-50 employees and maintains a website at www.orcosa.com. It has secured multiple rounds of funding totaling around $11M.

LATEST FUNDINGPrivate Placement

$6.0M

Announced 2026-11-12

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Orcosa Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES11-50

FOUNDED2020

HQEwing, NJ, United States

Industry

Biotechnology

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Orcosa co-founder Vincent T. Mileto named to NJBIZ 2025 People to Watch in Health Care.
Andy Drechsler joined as Chief Financial Officer to support growth.
European Patent No. 4 243 797 strengthens IP for ORC-144 CBD tablet.
Edward Sturchio and Robert Radie joined the Board of Directors.
Company advancing Phase 3 clinical work on cannabidiol for pain.